These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28639986)

  • 1. Chitinase-3-like protein-1 (YKL-40) before and after therapy in supraventricular arrhythmias.
    Michelakakis N; Neroutsos GJ; Perpinia AS; Farmakis D; Voukouti EG; Karavidas AJ; Parissis J; Georgiakaki MT; Pyrgakis VN
    J Cardiovasc Med (Hagerstown); 2017 Sep; 18(9):650-654. PubMed ID: 28639986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YKL-40 levels and atrial fibrillation in the general population.
    Marott SC; Benn M; Johansen JS; Jensen GB; Tybjærg-Hansen A; Nordestgaard BG
    Int J Cardiol; 2013 Aug; 167(4):1354-9. PubMed ID: 22525348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II blockade, YKL-40 and maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation.
    Tveit A; Seljeflot I; Smith P; Arnesen H; Svendsen JH
    Immunobiology; 2013 Oct; 218(10):1256-60. PubMed ID: 23731775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations.
    Liu L; Zhang X; Liu Y; Zhang L; Zheng J; Wang J; Hansbro PM; Wang L; Wang G; Hsu AC
    Respir Res; 2019 May; 20(1):95. PubMed ID: 31113430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein YKL-40 Levels in Plasma Are Associated with Fibrotic Changes on HRCT in Asbestos-Exposed Subjects.
    Väänänen T; Lehtimäki L; Vuolteenaho K; Hämäläinen M; Oksa P; Vierikko T; Järvenpää R; Uitti J; Kankaanranta H; Moilanen E
    Mediators Inflamm; 2017; 2017():1797512. PubMed ID: 28588347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum YKL-40 as a Marker of Left Atrial Fibrosis Assessed by Delayed Enhancement MRI in Lone Atrial Fibrillation.
    Canpolat U; Aytemir K; Hazirolan T; Özer N; Oto A
    Pacing Clin Electrophysiol; 2015 Dec; 38(12):1386-95. PubMed ID: 26256257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitinase-3-like Protein 1 (YKL-40) Is Expressed in Lesional Skin in Hidradenitis Suppurativa.
    Salomon J; Piotrowska A; Matusiak Ł; Dzięgiel P; Szepietowski JC
    In Vivo; 2019; 33(1):141-143. PubMed ID: 30587614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.
    Thongsom S; Chaocharoen W; Silsirivanit A; Wongkham S; Sripa B; Choe H; Suginta W; Talabnin C
    Tumour Biol; 2016 Jul; 37(7):9451-63. PubMed ID: 26781979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cavotricuspid isthmus dependent flutter is associated with an increased incidence of occult coronary artery disease.
    de Bono JP; Stoll VM; Joshi A; Rajappan K; Bashir Y; Betts TR
    Europace; 2010 Dec; 12(12):1774-7. PubMed ID: 20876273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma YKL-40: a potential biomarker for psoriatic arthritis?
    Jensen P; Wiell C; Milting K; Poggenborg RP; Østergaard M; Johansen JS; Skov L
    J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):815-9. PubMed ID: 22621388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
    Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
    Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children.
    Kyrgios I; Galli-Tsinopoulou A; Stylianou C; Papakonstantinou E; Arvanitidou M; Haidich AB
    Metabolism; 2012 Apr; 61(4):562-8. PubMed ID: 22036069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of serum YKL-40 in Behçet disease.
    Seo J; Ahn Y; Zheng Z; Kim BO; Choi MJ; Bang D; Kim DY
    Br J Dermatol; 2016 Jun; 174(6):1337-44. PubMed ID: 26708309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum YKL-40/chitinase 3-like protein 1 level is an independent predictor of atherosclerosis development in patients with obstructive sleep apnea syndrome.
    Bakırcı EM; Ünver E; Değirmenci H; Kıvanç T; Günay M; Hamur H; Büyüklü M; Ceyhun G; Topal E; Çoban TA
    Turk Kardiyol Dern Ars; 2015 Jun; 43(4):333-9. PubMed ID: 26142786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrations of the acute phase reactants high-sensitive C-reactive protein and YKL-40 and of interleukin-6 before and after treatment in patients with acromegaly and growth hormone deficiency.
    Andreassen M; Vestergaard H; Kristensen LØ
    Clin Endocrinol (Oxf); 2007 Dec; 67(6):909-16. PubMed ID: 17727678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between serum YKL-40 levels, mean platelet volume, and c-reactive protein in patients with cellulitis.
    Erturk A; Cure E; Cure MC; Parlak E; Kurt A; Ogullar S
    Indian J Med Microbiol; 2015 Feb; 33 Suppl():61-6. PubMed ID: 25657159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel inflammatory marker in dialysis patients: YKL-40.
    Okyay GU; Er RE; Tekbudak MY; Paşaoğlu Ö; Inal S; Öneç K; Paşaoğlu H; Altok K; Derici Ü; Erten Y
    Ther Apher Dial; 2013 Apr; 17(2):193-201. PubMed ID: 23551676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.
    Jaksch P; Taghavi S; Klepetko W; Salama M
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):273-81. PubMed ID: 24685381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High YKL-40 serum levels and its expression in the muscle tissues of patients with antisynthetase syndrome.
    Carboni RCS; Behrens Pinto GL; Shinjo SK
    Adv Rheumatol; 2021 Jul; 61(1):44. PubMed ID: 34225813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.